Inactive Instrument
Precision Therapeutics Inc Share Price Nasdaq
Stocks
US74033P1003
Biotechnology & Medical Research
| Market Cap | 87.82M 76.32M 71.25M 65.41M 123M 8.37B 125M 840M 329M 4.17B 330M 323M 13.77B | P/E 2024 |
-0.35x | P/E 2025 | -0.53x |
|---|---|---|---|---|---|
| Enterprise Value | 78.69M 68.39M 63.85M 58.61M 111M 7.5B 112M 753M 295M 3.74B 296M 289M 12.34B | EV / Sales 2024 |
4.23x | EV / Sales 2025 | 121x |
| Free-Float |
94.34% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Precision Therapeutics Inc
| 1 day | -7.56% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 57 | 08/02/2026 | |
| Director of Finance/CFO | - | 15/04/2026 | |
Kyle Okamoto
PSD | President | - | 31/03/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Daniel Handley
BRD | Director/Board Member | 66 | 18/02/2020 |
Charles L. Nuzum
CHM | Chairman | 78 | 08/02/2026 |
| Director/Board Member | 60 | 08/07/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -7.56% | -8.33% | - | - | 87.82M | ||
| +0.09% | +0.11% | -0.85% | +13.75% | 48.22B | ||
| -2.71% | -2.99% | +398.09% | +472.12% | 38.79B | ||
| -0.71% | +9.45% | +27.90% | +7.89% | 38.41B | ||
| -0.71% | -3.72% | +4.94% | +52.45% | 34.88B | ||
| -2.41% | +1.96% | +11.68% | +38.17% | 29.19B | ||
| -0.66% | -2.73% | +35.50% | +122.17% | 16B | ||
| -0.19% | -3.93% | - | - | 16.05B | ||
| +1.95% | +0.79% | +3.79% | +17.21% | 13.53B | ||
| -3.15% | -6.14% | -4.82% | -36.90% | 12.22B | ||
| Average | -1.26% | -0.66% | +59.53% | +85.86% | 27.48B | |
| Weighted average by Cap. | -0.46% | +0.15% | +75.87% | +103.61% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 1.62M 1.41M 1.32M 1.21M 2.28M 155M 2.32M 15.54M 6.08M 77.18M 6.1M 5.96M 255M | 125K 109K 102K 93.32K 176K 11.94M 179K 1.2M 469K 5.96M 471K 460K 19.64M |
| Net income | -12.66M -11.01M -10.28M -9.43M -17.79M -1.21B -18.1M -121M -47.45M -602M -47.57M -46.52M -1.99B | -233M -203M -189M -174M -327M -22.22B -333M -2.23B -873M -11.08B -876M -856M -36.54B |
| Net Debt | 1.4M 1.21M 1.13M 1.04M 1.96M 133M 2M 13.36M 5.23M 66.37M 5.24M 5.13M 219M | -9.12M -7.93M -7.4M -6.8M -12.82M -870M -13.04M -87.3M -34.19M -434M -34.27M -33.51M -1.43B |
Employees
-

















